Intravenous immunoglobulin and thymoglobulin induction treatment in immunologically high-risk kidney transplant recipients

被引：21

作者：

Akalin, E

Ames, S

Sehgal, V

Murphy, B

Bromberg, JS

Fotino, M

Friedlander, R

机构：

[1] Mt Sinai Med Ctr, Dept Nephrol, Recanati Miller Transplantat Inst, New York, NY 10029 USA

[2] Rogosin Immunogenet Lab, New York, NY USA

来源：

TRANSPLANTATION | 2005年 / 79卷 / 06期

关键词：

D O I：

10.1097/01.TP.0000146845.93929.EC

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

收藏

页码：742 / 742

页数：1

相关论文

共 4 条

[1] Intravenous immunoglobulin and Thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients
Akalin, E
Ames, S
Sehgal, V
Fotino, M
Daly, L
Murphy, B
Bromberg, JS
[J]. TRANSPLANTATION, 2003, 76 (10) : 1444 - 1447
[2] Cho Y W, 2001, Clin Transpl, P237
[3] Management of the highly HLA-sensitized patient. A novel role for intravenous gammaglobulin
Jordan, SC
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (08) : 691 - 692
[4] Anti-HLA antibodies after solid organ transplantation
McKenna, RM
Takemoto, SK
Terasaki, PI
[J]. TRANSPLANTATION, 2000, 69 (03) : 319 - 326